Key points are not available for this paper at this time.
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I ("Risk Of Bias In Non-randomised Studies - of Interventions"), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jonathan Sterne
Miguel A. Hernán
Barnaby C Reeves
Notes and Queries
BMJ
Harvard University
Massachusetts Institute of Technology
University of Oxford
Building similarity graph...
Analyzing shared references across papers
Loading...
Sterne et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69027ba329206953ba14960e — DOI: https://doi.org/10.1136/bmj.i4919
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: